Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Immune checkpoint inhibitors (ICIs) have revolutionised cancer treatment. However, immune-
related adverse events (irAEs) are a common side effect which can mimic infection …
related adverse events (irAEs) are a common side effect which can mimic infection …
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update
BJ Schneider, J Naidoo, BD Santomasso… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE To increase awareness, outline strategies, and offer guidance on the
recommended management of immune-related adverse events (irAEs) in patients treated …
recommended management of immune-related adverse events (irAEs) in patients treated …
Effect of COVID-19 on lungs: focusing on prospective malignant phenotypes
Simple Summary According to the coronavirus virus resource center of Johns Hopkins
Medicine, more than 75 million people are presently affected worldwide, including 1.7 …
Medicine, more than 75 million people are presently affected worldwide, including 1.7 …
[HTML][HTML] Inhibitory immune checkpoint molecules and exhaustion of T cells in COVID-19
M Barnova, A Bobcakova, V Urdova… - Physiological …, 2021 - ncbi.nlm.nih.gov
Summary COVID-19 (Coronavirus Disease) is an infectious disease caused by the
coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which …
coronavirus SARS-CoV-2 (Severe acute respiratory syndrome Coronavirus 2), which …
Immune checkpoint inhibition in COVID-19: risks and benefits
PS Pezeshki, N Rezaei - Expert Opinion on Biological Therapy, 2021 - Taylor & Francis
Introduction Immune checkpoint inhibition (ICI) is a novel cancer immunotherapy, which is
administered in patients with metastatic, refractory, or relapsed solid cancer types. Since the …
administered in patients with metastatic, refractory, or relapsed solid cancer types. Since the …
[HTML][HTML] Remdesivir use in the coronavirus disease 2019 pandemic: A mini-review
CJ Yang, YJ Wei, HL Chang, PY Chang… - Journal of Microbiology …, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative viral
pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical …
pathogen of coronavirus disease 2019 (COVID-19), appears to have various clinical …
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
M Bersanelli, D Giannarelli… - … in medical oncology, 2020 - journals.sagepub.com
Background: This prospective, multicentre, observational INVIDIa-2 study is investigating the
clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune …
clinical efficacy of influenza vaccination in advanced-cancer patients receiving immune …
Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
Patients with severe COVID‐19 often suffer from lymphopenia, which is linked to T‐cell
sequestration, cytokine storm, and mortality. However, it remains largely unknown how …
sequestration, cytokine storm, and mortality. However, it remains largely unknown how …
Cancer and immune checkpoint inhibitor treatment in the era of SARS-CoV-2 infection
T Gambichler, J Reuther, CH Scheel, L Susok, P Kern… - Cancers, 2020 - mdpi.com
Simple Summary The introduction of immune checkpoint inhibitors (ICI) in 2011
revolutionized the management of many solid cancers and hematological malignancies …
revolutionized the management of many solid cancers and hematological malignancies …
[HTML][HTML] Association of soluble PD-L1 and NLR combination with 1-Year mortality in patients with COVID-19
L Akhmaltdinova, I Mekhantseva, L Turgunova… - International …, 2024 - Elsevier
Purpose Understanding the relationship between patient immune characteristics, disease
severity, and mortality represents a critical step in the fight against COVID-19. Elevated …
severity, and mortality represents a critical step in the fight against COVID-19. Elevated …